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The use of modern neuroimaging approaches has demonstrated resting-state regional
cerebral blood ﬂow (rCBF) to be tightly coupled to resting cerebral glucose metabolism
(rCMRglu) in healthy brains. In schizophrenia, several lines of evidence point toward
aberrant neurovascular coupling, especially in the prefrontal regions. To investigate this,
we used Signed Differential Mapping to undertake a voxel-based bimodal meta-analysis
examining the relationship between rCBF and rCMRglu in schizophrenia, as measured by
arterial spin labeling (ASL) and 18Flurodeoxyglucose positron emission tomography (FDGPET) respectively. We used 19 studies comprised of data from 557 patients and 584
controls. Our results suggest that several key regions implicated in the pathophysiology of
schizophrenia such as the frontoinsular cortex, dorsal ACC, putamen, and temporal pole
show conjoint metabolic and perfusion abnormalities in patients. In contrast, discordance
between metabolism and perfusion were seen in superior frontal gyrus and cerebellum,
indicating that factors contributing to neurovascular uncoupling (e.g. inﬂammation,
mitochondrial dysfunction, oxidative stress) are likely operates at these loci. Studies
enrolling patients on high doses of antipsychotics had showed larger rCBF/rCMRglu
effects in patients in the left dorsal striatum. Hybrid ASL-PET studies focusing on these
regions could conﬁrm our proposition regarding neurovascular uncoupling at superior
frontal gyrus in schizophrenia.
Keywords: schizophrenia, arterial spin labeling, positron emission tomography, cerebral blood ﬂow, cerebral
glucose metabolism, dorsal anterior cingulate cortex

INTRODUCTION
Since the time of Ernst von Feuchtersleben who coined the term psychosis in 1845 (1), psychotic
disorders have been suspected to be associated with disturbances in the cerebral blood supply. This
has been thoroughly investigated through the use of modern neuroimaging techniques, which have
uncovered abnormalities in the resting-state regional cerebral blood ﬂow (rCBF) across various
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regions with concordance or discordance between metabolism
and perfusion have been reported to our knowledge. To address
this gap, we undertook a voxel-based bimodal meta-analysis to
examine the relationship between rCBF and rCMRglu in
schizophrenia. We hypothesized that several brain regions
would show combined abnormalities of perfusion and
metabolism, while uncoupling of these two parameters would
be observed in prefrontal regions. The meta-analysis was
performed using the anisotropic effect size version of seedbased d mapping (AES-SDM). AES-SDM is a software used to
create meta-analytic maps of studies that use MNI or Talairach
coordinates to denote brain regions of signiﬁcant group
differences, weighted by sample size, variance, and betweenstudy heterogeneity. AES-SDM was also used to conduct metaregression analyses to quantify the effect of nuisance variables
such as age, gender, duration of illness, antipsychotic dosage, and
illness severity on the heterogeneity of the ﬁndings. It is
important to note that the absolute values of the outcome
measures in various studies differ based on the quantiﬁcation
procedures employed in both ASL and PET studies. Our metaanalysis is based on effect-sizes of differences between two
groups, rather than the absolute measurement metrics. As
such, this study is an early probe to assess the likelihood of
regions with neurovascular uncoupling in schizophrenia.

brain regions in schizophrenia. The frontal lobe, anterior
cingulate cortex, temporal lobe and occipital lobe, among
others, are regions that have been showed to differ with respect
to rCBF in patients compared to healthy subjects (2). In healthy
brains, rCBF is tightly coupled to resting cerebral glucose
metabolism (rCMRglu), which increases with synaptic activity.
This coupling, also known as functional hyperemia, is
accomplished by the coordinated activity of a group of cells
(comprised of astrocytes, endothelial cells, and neurons) called
the neurovascular unit. These cells detect changes in synaptic
activity, and initiate vasodilation or vasoconstriction responses
to accommodate for the resultant changes in rCMRglu (3).
Two imaging modalities that have been very useful in studies
investigating rCBF and rCMRglu in patients are arterial spin
labeling (ASL), and positron emission tomography (PET). ASL is
a relatively recent neuroimaging modality that was developed as
a non-invasive analog to gadolinium contrast MRI for the
measurement of rCBF. Instead of using a potentially toxic
contrast to visualize blood ﬂow, a radiofrequency pulse is
applied at the neck region to magnetize blood water molecules
ﬂowing into the brain. This allows for the capturing of a “tagged”
image in the area of interest by MRI. By quantitatively
comparing the tagged image with a (non-RF pulse) control
image, researchers can construct an accurate representation of
cerebral blood ﬂow (4). Likewise, an accurate representation of
rCMRglu can be constructed using PET neuroimaging. PET is a
functional imaging technique that uses a radioactive tracer to
measure the regional activity of the biological molecule that the
tracer is attached to. A common tracer is 18ﬂurodeoxyglucose
(FDG), and it is often employed in neuroimaging studies to
measure the cerebral metabolic rate of glucose (5). ASL and FDG
PET imaging have been used in various case-control studies to
quantify case-control differences between patients with
schizophrenia and healthy controls.
The vascular hypothesis of schizophrenia suggests that one of
the underlying mechanisms of schizophrenia is the disruption of
the appropriate rCBF response to changes in cerebral metabolic
activity (6). In healthy brains, the integrity of the neurovascular
unit is essential in maintaining functional hyperemia and
ensuring that changes in rCBF are tightly and congruently
coupled to changes in rCMRglu. Disruption of this coupling
(low rCBF with high rCMRGlu) can lead to insufﬁcient support
for synaptic activity, triggering synaptic loss or promoting gliamediated inﬂammatory response that can result in a cascade of
further damage to the synaptic and neuronal homeostasis
required for intact cerebral function (7). Neurovascular
uncoupling can also impair oxygen metabolism, induce
mitochondrial dysfunction and oxidative stress leading to
neuronal death, and brain tissue atrophy (8).
Identifying regions where this uncoupling occurs is
extremely important as the underlying mechanism and its
pathophysiological relationship to schizophrenia can be studied
in more detail. This has been done to some degree; uncoupling
has been demonstrated to occur in patients with schizophrenia,
especially in the prefrontal regions during task-related activities
(9). However, no simultaneous ASL-PET studies identifying
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METHODS
Search
Two literature searches were conducted across four databases
(PubMed, PsycInfo, Scopus and Web of Science). The search
terms “arterial,” “spin,” “labeling,” and “schizophrenia” yielded
83 results, and the terms “FDG,” “PET” and ‘schizophrenia’
yielded 201 results (after duplicates were removed). The
following inclusion criteria was applied: Case control studies
reporting voxelwise ASL or FDG-PET changes in patients with
schizophrenia compared to healthy controls, using MNI or
Talairach coordinates. Studies that met the inclusion criteria,
but did not report all of the data required for the meta-analysis
were not immediately excluded in the hope that a
correspondence with the authors of these studies could be
initiated to obtain the missing data. Studies that did not use
ICD 10 or DSM IV/5 diagnostic criteria for schizophrenia or did
not investigate the whole brain were excluded. Twenty-one ASL
and eight PET papers remained after inclusion and exclusion
criteria were applied to the search results. Of these, 12 papers did
not report their data in a format that was compatible with our
meta-analysis. We contacted the authors of these papers and
were only able to obtain additional data from two studies (2, 10).
Three of the papers we ﬁnally included in our meta-analyses (11–
13), investigated schizophrenia binary subgroups (for example,
catatonic and non-catatonic schizophrenia patients) compared
to controls. The ﬁnal meta-analyses thus used 16 datasets from
14 ASL papers (2, 10–12, 14–23) and 6 datasets from 5 PET
papers (13, 24–27) to generate results. The literature search is
summarized in the ﬂowchart in Figure 1.
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FIGURE 1 | Flowchart of literature search.

ASL Study Quality

PET Study Quality

The methodological quality of the included studies was assessed
by scoring four criteria encompassing all aspects of data
collection and analysis which can confound the quality of the
ASL data and subsequently bias the validity and reliability of the
study inferences. The four criteria are: (1) participant selection,
(2) image acquisition, (4) image preprocessing and analysis, and
(5) statistical analysis techniques. The criteria for appropriate
quality standards for image acquisition were based on the
recommended implementations of ASL by the ISMRM
Perfusion Group and the European ASL in Dementia (28). The
minimum standard requirement for image acquisition were
modiﬁed since 36% of the included ASL studies were
completed 2–3 years after the recommended guidelines.
Emphasis was placed on determining whether the included
studies speciﬁed imaging parameters that impact the signal-tonoise in ASL images. ASL image quality increases as the signalto-noise increases. The criteria were scored as either “adequate,”
if all aspects of the criteria were reported and met minimum
standard, or “inadequate,” if aspects of the criteria were missing
or did not meet minimum standard, or “unclear,” if no clear
conclusion could be drawn from the information provided.
These criteria are further detailed in Table 1.

The methodological quality of the included studies was assessed
by scoring ﬁve criteria encompassing all aspects of data collection
and analysis which can confound the quality of the PET data and
subsequently bias the validity and reliability of the study
inferences. The ﬁve criteria are (1) participant selection, (2)
participant preparation, (3) image acquisition, (4) image
preprocessing and analysis, and (5) statistical analysis
techniques. The criteria for appropriate quality standards for
participant preparation and image acquisition were based on the
SNMMI Procedure guideline for FDG PET Brain Imaging
Version 1.0 (29). The criteria were scored as either “adequate,”
if all aspects of the criteria were reported and met minimum
standard, or “inadequate,” if aspects of the criteria were missing
or did not meet minimum standard, or “unclear,” if no clear
conclusion could be drawn from the information provided.
These criteria are further detailed in Table 2.
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Mean Analysis
AES-SDM was used to generate a meta-analytic map for the
compiled datasets, using permutation tests to determine
statistical signiﬁcance of results. As recommended by Radua
et al., default SDM parameters were used (FWMH = 20mm,
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TABLE 1 | Quality analysis tool for included arterial spin labeling (ASL) studies.
Criteria

TABLE 2 | Quality assessment tool for included positron emission tomography
(PET) studies.

Minimum standard
Criteria

1 Participant
Selection

2 Image
acquisition

3 Image
analysis

4 Statistical
analysis

I. Participants in the study should be subjects with a diagnosis
of schizophrenia or schizoaffective disorder established
through clinical chart review using structured diagnostic
interviews based on DSM-IV/V and healthy controls between
ages of 18 and 65 years.
II. Participants were selected following a prospective inclusion
and exclusion criteria.
III. Details should be provided about age distribution, female to
male ratio and disease description as minimum information
(subject demographics table).
IV. Total number of subjects per group were >10.
Emphasis placed on factors that impact signal-to noise.
I. Hardware considerations: Scanner manufacturer and Field
Strength speciﬁed was 1.5 T or 3T.
II. The speciﬁc ASL pulse labeling approach was speciﬁed. The
four labeling approaches are: continuous (CASL), pseudocontinuous (pCASL), pulsed (PASL), and velocity-selective
(VS-ASL).
III. Time between labeling and imaging (post-label delay) was
speciﬁed
IV. Total imaging time was speciﬁed, or enough information was
speciﬁed to estimate total imaging time (repetition time, echo
time, and the number of label and control pairs).
I. Measures to restrict motion or correct motion was speciﬁed.
ASL is sensitive to motion and motion can reduce signal-tonoise in ASL.
II. The following parameters used in calculating CBF must be
speciﬁed:
III. The blood-brain partition coefﬁcient used
IV. The T1 of blood used
V. The Labeling efﬁciency used
VI. The use of a brain atlas or template for spatial normalization
was speciﬁed.
I. Statistical methods for controlling multiple comparisons were
speciﬁed for signiﬁcant differences.
II. The inﬂuence of age and gender was controlled/removed. **
Age and gender are signiﬁcant CBF modiﬁers (Clement et al.
JCBFM 2017)

1 Participant
Selection

I. Participants in the study should be subjects with a diagnosis
of schizophrenia or schizoaffective disorder established
through clinical chart review using structured diagnostic
interviews based on DSM-IV/V and healthy controls
between ages of 18 and 65 years.
II. Participants were selected following a prospective inclusion
and exclusion criteria.
III. Details should be provided about age distribution, female to
male ratio and disease description as minimum information
(subject demographics table).
IV. Total number of subjects per group were >10.
2 Participant
I. Participants fasted for 4–6 hours.
preparation II. The use of caffeine or alcohol, substance use/abuse/
dependence, or psychoactive medications that may affect
cerebral glucose metabolism were speciﬁed.
III. The blood glucose was checked prior to FDG-injection and
was no greater than 150 – 200 mg/dl.
IV. Participants were kept in a stable environment during PET
uptake period. This includes a quiet, dimly-lit room and eyes
open/closed.
3 Image
I. Scanner make and model was speciﬁed.
acquisition
II. Administered FDG dose was within 185–740 Mbq
III. Uptake period within 20–60 min
IV. Emission scan duration of a minimum of 15 min
4 Image
I. An attenuation correction method was speciﬁed.
analysis
II. The reconstruction algorithm was speciﬁed.
III. Measures to restrict motion or correct motion was speciﬁed.
IV. The use of a brain atlas or template for spatial normalization
was speciﬁed.
V. An appropriate reference region selection (cerebellar cortex
or whole brain) for count normalization was reported.
5 Statistical
I. Exclusion of none gray matter voxels was reported.
analysis
II. Statistical methods were speciﬁed for signiﬁcant differences
III. The inﬂuence of age and gender was controlled/removed.

Each criterion was categorized as follows:
Adequate: All aspects of the criteria were reported and met minimum standard.
Inadequate: Aspects of the criteria were missing or did not meet minimum standard.
Unclear: No clear conclusion could be drawn from the information provided.

Each criterion was categorized as follows:
Adequate: All aspects of the criteria were reported and met minimum standard.
Inadequate: Aspects of the criteria were missing or did not meet minimum standard.
Unclear: No clear conclusion could be drawn from the information provided.

large effect sizes (based on (32), implemented via ‘MetaNSUE’
function of R (33)).

Conjunction Analysis of rCBF and
rCMRglu Changes

cluster extent = 10 voxels), but with a more conservative
uncorrected p-value (P < 0.001 compared to P < 0.005) (30).
We assessed the robustness of the results by assessing the
residual heterogeneity, and by using a sensitivity analysis (jackknife approach). This was done by repeating the meta-analysis
multiple times, each time leaving out one of the studies that was
originally included it. A score was given to each reported brain
region corresponding to the number of times it was reported in
the meta-analyses. In addition, we examined the peaks of
maximum heterogeneity to check if they are driven by a small
number of “outliers.” We also drew funnel plots for each peak
voxel reported in the main analysis using the Bias Analysis
option of the SDM (version 6.21) and statistically assessed for
asymmetry in the funnel plot (using ‘metabias’ function of R
(31)) and a test for publication bias favoring small studies with

Frontiers in Psychiatry | www.frontiersin.org

Minimum standard

We used multimodal analysis to identify which of the brain
regions identiﬁed in our meta-analysis showed signiﬁcant
changes in both rCBF and rCMRglu. Our goal was not
necessarily to demonstrate a physiological correlation between
these measures, but rather to identify which of our results were
supported by data from both ASL and PET imaging studies. As
this was a four-tailed test (allowing for positive and negative
results across two modalities), we used a conservative threshold
of p<0.0025 for cluster inclusion and p<0.00025 (10-times more
stringent) for peak identiﬁcation, based on the minimum
acceptable threshold for conjunction in each individual
modality map as p<0.05. This method, described in detail by
Radua et al. (34), has been used in various studies for bimodal
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% Females
Control Age
Patient Age
Controls

497 ± 210
461.3 ± 346.4
373.6 ± 359.4
332.2 ± 546.75
350.5 ± 571.26
453.2 ± 342.9
518.9 ± 235.7
604.8 ± 459.2
373.7
442.5 ± 241.03
NA
556.2
546.4
NA
400.2 ± 344.2
622.1 ± 418.0
633.2 ± 415.6
NA
NA
NA
NA
NA
14.3
12.8 ± 12.0
10.5 ± 10.6
NA
NA
10.2 ± 8.2
NA
16.8 ± 11.3
NA
8.9 ± 13.29
NA
2.79 ± 2.6
14.3
1.5 ± 1.75
12.2 ± 12.3
20.5 ± 10.0
7.5 ± 4.1
7.89
2.3 ± 1.8
15.57 ± 11.3
18.42 ± 10.3
2.1 ± 7.8
19.7 ± 6.0
21.9 ± 6.9
16.4 ± 4.1
32.0 ± 5.37
25.19 ± 5.58
20.1 ± 9.0
18.9 ± 6.1
14.9 ± 6.2
NA
18.00 ± 7.59
21.4 ± 7.9
15.5 ± 6.1
23.1 ± 8.2
23 ± 10
18.4 ± 5.1
NA
16.7 ± 2.5
NA
NA
23.2 ± 6.8
19.7 ± 7.6
20.66 ± 5.44
19.6 ± 6.7
16.0 ± 8.1
17.9 ± 6.2
19.19 ± 3.53
12.63 ± 3.76
17.0 ± 7.8
19.9 ± 6.8
15.3 ± 5.8
NA
11.73 ± 4.45
20.2 ± 2.9
13.48 ± 4.8
14.4 ± 6.4
21 ± 9
18.2 ± 6.4
NA
15.9 ± 3.0
NA
NA
24.5 ± 6.4
11.0 ± 5.3
26.33 ± 4.15
76.6 ± 17.4
77.1 ± 18.9
67.1 ± 16.3
32 ± 5.37
25.2 ±5.58
71.3 ± 22.7
75.5 ± 17.3
61.8 ± 19.3
NA
54.2 ± 14.11
43.1 ± 8.5
63.9
69.4 ± 17.2
92 ± 22
72.6 ± 17.1
NA
33.8 ± 4.8
NA
84.7 ± 23.6
43.7 ± 6.4
33.6 ± 5.3
45 ± 8.2
43.75
26.67
37.04
50
31.25
43
47.06
52.78
40
27.27
27.27
38.46
14.29
48
61.7
57.90
48.27
31.37
36.84
37.5
50
NA

Age and duration of illness are given in years.

Our meta-analysis drew data from 22 datasets from 19 studies. In
total, 557 patients with schizophrenia were compared to 584
healthy controls. Table 3 lists the demographic data for the
participants in each study. Most studies published information
regarding number of patients and healthy controls, patient
gender distribution, patient age, duration of illness,
antipsychotic dosage, syndrome severity, type of scan, and
study quality. Almost all of the studies matched healthy
controls to patients for at least age and gender, with some

ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
ASL
PET
PET
PET
PET
PET
PET

Study Demographics

Kindler 2018
Walther 2017 (Catatonia)
Walther 2017 (Non-Catatonia)
Pinkham 2015 (Paranoid)
Pinkham 2015 (Non-Paranoid)
Zhu 2015
Kindler 2015
Ota 2014
Pinkham 2011
Walther 2011
Scheef 2010
Horn 2009
Oliveira 2018
Cui 2017 (Non-AVH)
Stegmayer 2017
Liu 2012
Park 2009
Desco 2002
Kim 2017
Ben-Shachar 2006 (HPS)
Ben-Shachar 2006 (LPS)
Horga 2014

RESULTS

Patients

The peak coordinates of various regions of interest identiﬁed by the
conjunction and disjunction analysis were used to determine the
brain network connectivity of these regions. This was done using
the Neurosynth functional connectivity meta-analytical database.

Modality

Querying Functional Connectivity
Differences

Study

TABLE 3 | Demographic table for datasets included in meta-analysis, as well as the quality scores for each study.

PANSS

We explored the inﬂuence of age, gender, duration of illness,
PANSS positive, and negative symptom severity, and overall dose
of antipsychotic medications (in chlorpromazine equivalents) on
the reported effect-sizes. To reduce spurious relationships, in line
with prior studies (36) we used a probability threshold of 0.0005,
and tested the slope (1m0) (e.g. comparing effect sizes in studies
with lowest vs. highest values of the predictor variable of
interest), and restricted meta-regression to ﬁndings detected in
the main analyses (38). We performed a separate metaregression for each of the variables being investigated. We also
visually inspected the regression plots from peak coordinates and
discarded slopes driven by <5 studies (30).

39.4 ± 12.3
38.6 ± 13.6
38.6 ± 13.6
33.64 ± 12.42
33.64 ± 12.42
33.3 ± 10.4
39.8 ± 12.6
37.9 ± 13.0
35.73
31.71 ± 6.08
30
26.6 ± 4.6
31.1 ± 5.8
26 ± 5
36.7 ± 12.9
NA
3.9 ± 3.0
13.16
30.7 ± 7.9
34.5 ± 11.5
34.5 ± 11.5
NA

Meta-Regression Analysis

41.6 ± 13.4
35.9 ± 12.7
37.1 ± 10.6
38.5 ± 7.71
38.8 ± 13.24
33.6 ± 8.6
41.5 ± 12.9
37.9 ± 12.6
35.7
35.3 ± 12.54
32
29.6 ± 11.2
32.8 ± 7.8
24 ± 5
38.2 ± 11.4
NA
29.8 ± 3.9
31.93
32.6 ± 12.0
35.9 ± 11.8
42.7 ± 15.3
NA

PANSS Positive

PANSS Negative

Duration of Illness

We used the meta-regression tool to identify which of the brain
regions identiﬁed in our meta-analysis showed signiﬁcant
disjoint or “uncoupled” changes in rCBF and rCMRglu. We
assigned a binary value to each study corresponding to the
measure being investigated (rCBF - 0; rCMRglu - 1) and tested
the slope (1m0) of the effect of the measure (ASL vs PET) on
effect-sizes reported in the SDM. A signiﬁcant positive regression
value for a given brain region indicates an uncoupled increase in
rCMRglu or an uncoupled decrease in rCBF, and a signiﬁcant
negative regression value indicates an uncoupled decrease in
rCMRglu or an uncoupled increase in rCBF. In order to
determine the appropriate case, each of the results of the
regression analysis were cross-referenced to the brain regions
identiﬁed by the primary meta-analysis. We used MRIcron
software to generate visual representations of the ﬁndings.

31
41
41
25
25
94
27
42
24
14
25
13
28
25
30
20
21
18
18
8
8
8

CLPZ eq.

Disjunction Analysis of rCBF and rCMRglu
Changes

32
15
27
16
16
100
34
36
30
11
11
13
28
25
20
19
29
51
19
8
8
9

conjunction meta-analysis (35–37). We used MRIcron software
to generate visual representations of the ﬁndings.

0.8
0.53
0.53
0.93
0.93
0.73
0.73
0.73
0.93
1.00
0.93
0.87
1.00
0.87
1.00
0.67
0.65
0.6
0.75
0.65
0.65
0.8
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median cingulate, right middle occipital gyrus, left inferior
frontal gyrus, left superior occipital gyrus, and right superior
frontal gyrus. Other than the right superior frontal gyrus, which
only survived 17 cross-validations, each of the other regions
survived at least 21 cross-validations. None of the reported peaks
had asymmetric funnel plot, or excess signiﬁcance bias (Table 5).
Moderate heterogeneity (I2>40%) was noted for left striatum, left
temporal pole, right anterior thalamic projections, and left
inferior frontal gyrus, while all other regions had low levels
of heterogeneity.

studies matching controls for other variables such as level of
education. Duration of illness, antipsychotic dosage and PANSS
scores ranged from 25.2 (SD 5.58) to 92.0 (SD 22) for ASL studies
and from 33.8 (SD 5.3) to 84.7 (SD 23.6) for PET studies. With a
few exceptions, all included ASL studies used a 3T scanner with a
pCASL technique to obtain results and only included patients
diagnosed with schizophrenia speciﬁcally. One study (14) used a
pASL technique, one study (15) used a 1.5T MRI scanner and
three studies (10, 16, 17), included individuals with schizoaffective
disorder in their patient groups. All PET studies only included
patients diagnosed with schizophrenia disorder speciﬁcally. The
authors from studies with missing clinical information were
contacted, and some of the unpublished data was retrieved for
this review.

Conjunction and Disjunction Analyses of
rCBF and rCMRglu Changes
Among patients with schizophrenia, we observed a conjoint
reduction in rCBF and rCMRglu in the right median cingulate
gyrus and left inferior frontal gyrus. A conjoint increase in rCBF
and rCMRglu was noted in the right putamen and right inferior
temporal gyrus. (Voxel probability threshold: p=0.0025, Peak
height threshold: p=0.00025, Cluster extent threshold: 10 voxels).
Regional neurovascular uncoupling was notable in the superior
frontal gyrus (reduced rCMRglu, normal rCBF) and cerebellum
(increased rCMRglu, normal rCBF). These regions are visually
represented in Figure 3.

Study Quality
The average quality scores for the ASL and PET studies used in the
meta-analysis were 0.84 and 0.69 respectively. Among the ASL
studies, the lowest quality score was 0.53 (11) and among the PET
studies the lowest quality score was 0.6 (13). The Quality Index
Scores for these studies are visually represented in Figure 2.

Mean Analysis
The SDM analysis showed several brain regions of signiﬁcant
difference in rCBF or rCMRglu between patients and healthy
controls. These results are listed in Table 4. Patients had
signiﬁcantly increased neurological activity in the right
lenticular nucleus, left striatum, right inferior temporal gyrus,
left temporal pole, right thalamus, and corpus callosum. Patients
had signiﬁcantly reduced neurological activity in the right

Meta-Regression Analysis
Meta-regression analysis was conducted to investigate the
relationship between the change in rCBF or rCMRglu in the
regions identiﬁed by the meta-analysis and various nuisance
variables of interest. Illness duration was found to be negatively
correlated to rCBF/rCMRglu changes in the left inferior frontal
gyrus. In addition, we found that higher antipsychotic dose
exposure attenuated the effect size of the patient-control
differences in right middle occipital and left striatal rCBF or
rCMRglu. We also noted that lower negative symptom burden
also related to attenuated effect size of the patient-control
differences in medial occipital rCBF or rCMRglu. Interestingly,
patient samples receiving lower average antipsychotic doses were
reporting higher average PANSS negative symptom scores (r=−0.6,
p=0.03, df=12; Supplementary Figure S3). The meta-regression
ﬁndings are described in the supplementary data (Table S1).

Querying Functional Connectivity
Differences
Figure 4 highlights the anterior cingulate region, which showed
conjoint and disjoint ﬁndings from different brain networks. The
ventral cluster had reduced rCMRglu as well as reduced rCBF and
was found to be well connected to the Salience Network, while the
more dorsal cluster had normal rCBF despite reduced metabolism,
and seems to participate in the frontoparietal executive network.

DISCUSSION
To our knowledge, this is the ﬁrst bimodal neuroimaging metaanalysis which combines information from whole brain FDGPET studies investigating resting metabolic state, and ASL

FIGURE 2 | The Quality Index Score is the proportion of studies that are
scored as adequate, inadequate, or unclear.
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TABLE 4 | Brain regions of signiﬁcant difference in regional cerebral blood ﬂow (rCBF) or resting cerebral glucose metabolism (rCMRglu) between patients with
schizophrenia and controls.
Region

SDM Z

MNI Coordinate

Cluster Size

P value

Jack-knife Score

Cluster breakdown

BA48
BA34
BA48
BA34
BA20
BA36
BA20
BA36

Patients>controls
Blobs of ≥ 59 voxels with all voxels SDM-Z ≥ 1.655 and all peaks SDM-Z ≥ 1.982
Right Putamen

3.517

28,4,12

1411

<0.0001

22

Left Striatum

3.186

−22,2,6

1080

<0.0001

22

Right Inferior Temporal Gyrus

3.186

42,2,-42

596

<0.0001

22

Left Temporal Pole

2.470

−34,0,−44

295

0.0005

21

Right Anterior Thalamic Projections
Corpus Callosum

2.204
1.982

18,–22,12
18,−28,4

103
59

0.0005
0.001

21
21

n/a

Controls>patients
Blobs of ≥ 101 voxels with all voxels SDM-Z ≤ –1.894 and all peaks SDM-Z ≤ –2.218
Right Median Cingulate Gyrus

−2.829

8,26,32

1292

0.0005

22

Right Middle Occipital Gyrus

−2.873

30,−92,12

357

<0.0001

21

Left Superior Occipital Gyrus

−2.641

−16,−100,14

274

<0.0001

22

Left Inferior Frontal Gyrus, (Triangular)

−2.708

−42,22,-2

647

<0.0001

21

Right Superior Frontal Gyrus, (Dorsolateral)

−2.218

20,20,56

101

0.001

17

BA24
BA32
BA18
BA19
BA17
BA18
BA47
BA45
BA48
BA8

Jack-knife analysis was scored out of 22. Voxel threshold: P < 0.005; Peak height threshold: peak SDM-Z > 1.000; Extent threshold: cluster size ≥ 10 voxels.

studies investigating the resting blood ﬂow in schizophrenia. We
report three major ﬁndings: 1. The frontoinsular cortex and the
bilateral dorsal anterior cingulate cortex show reduced rCBF as
well as rCMRglu in schizophrenia; 2. The bilateral dorsal striatum
and the temporal pole show increased rCBF as well as rCMRglu in
schizophrenia; 3. Brain regions with rCBF changes consistently
show rCMRglu changes, but brain regions with rCMRglu changes
are not always coupled with rCBF changes, especially in the
superior frontal (dorsomedial ACC) and cerebellar cortices.
The frontoinsular cortex and bilateral dorsal anterior
cingulate cortex, which showed reduced rCBF as well as
rCMRglu in schizophrenia, belong to the Salience Network
(SN) (39). The SN is considered to be a cognitive control
network that performs the critical function of switching from
introspective default-mode of brain activity to extrospective taskprocessing activity (40). Many prior studies have extensively
investigated the connectivity within the SN and between the SN
and other brain regions, and have highlighted the concentration
of gray matter reduction in schizophrenia around the nodes of
the SN (41). Our ﬁndings once again highlight the primary role
that the SN plays in the diagnostic construct of schizophrenia
(42). The neural basis of insula-related observations in fMRI
studies have been considered with some caution given the
vascular anatomy of this region (43). Our bimodal analysis
establishes that defects in glucose utilization of SN nodes are a
key aspect of the pathophysiology of schizophrenia. We also note
that the frontoinsular cortex shows a trend for reduction in
rCBF/rCMRglu in patients with longer duration of illness,
indicating the possibility of a progressive defect in this key node.

TABLE 5 | Estimates of between-study heterogeneity and publication bias from
peak regions of signiﬁcant difference in regional cerebral blood ﬂow (rCBF) or resting
cerebral glucose metabolism (rCMRglu) between patients with schizophrenia and
controls.
Region

MetaBias test
(z/p value)

Excess signiﬁcance
I2
statistic
test (p value)

(Regions showing increased rCBF/CMRglu in patients)
Right Putamen
Left Striatum
Right Inferior Temporal
Gyrus
Left Temporal Pole
Right Anterior Thalamic
Projections
Corpus Callosum

z: −0.67,
p=0.502
NA
Z: −0.94,
P = 0.349
Z: −0.29,
P = 0.829
Z: −1.41,
P = 0.304
Z: −0.75,
P = 0.453

0.86

3.47

0.376
0.842

50.54
7.37

0.897

45.49

0.937

41.44

0.894

1.74

(Regions showing decreased rCBF/CMRglu in patients)
Right Median Cingulate
Gyrus
Right Middle Occipital
Gyrus
Left Superior Occipital Gyrus
Left Inferior Frontal
Gyrus, (Triangular)
Right Superior Frontal
Gyrus, (Dorsolateral)

Z: 0.62,
P = 0.538
Z: 0.16,
P = 0.873
NA
Z: 0.48,
P = 0.632
Z: 0.09,
P = 0.932

0.492

30.1

0.671

2.21

NA
0.895

15.1
44.1

0.975

31.6

These results are obtained using Bias Test function of the Signed Differential Mapping
software version 6.21.
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A

B

FIGURE 3 | Regions of conjoint ﬁndings are shown on the left (A), and regions with disjoint ﬁndings are shown on the right (B). Bilateral striatum and temporal pole
were found to have conjoint increases in regional cerebral blood ﬂow (rCBF) and resting cerebral glucose metabolism (rCMRglu) (shown in blue). Left frontoinsular
cortex and bilateral dorsal anterior cingulate cortex were found to have conjoint reductions in rCBF and rCMRglu. Regional neurovascular uncoupling was notable in
the left superior frontal gyrus (−6,30,44; Left BA 8; SDM-z = −2.001, p=0.00033, reduced rCMRglu, normal rCBF – shown in yellow) and left cerebellum (−38,−66,
−34; crus I and II; SDM-Z=2.27, p=0.00026, no. of voxels = 129; increased rCMRglu, normal rCBF – shown in green).

FIGURE 4 | The conjunction and disjunction ﬁndings in the anterior cingulate region are shown. The more ventral cluster (red; 6, 22, 34) has reduced resting
cerebral glucose metabolism (rCMRglu) as well as reduced regional cerebral blood ﬂow (rCBF), while the more dorsal (yellow; −6, 30, 44) has normal rCBF despite
reduced metabolism.

binding (47), hypermetabolism in this region may be related to
acute psychotic symptoms as shown by Crespo-Feccorro et al.,
though our meta-regression was not able to conﬁrm this notion.
Both lower dose exposure and higher negative symptom burden
related to the exaggerated effect size of the patient-control
differences in middle occipital rCBF/rCMRglu. These ﬁndings
are intriguing in the context of recent observations implicating
occipital hypometabolism as an early biomarker of anti–NMDA
receptor encephalitis, a condition with a high propensity to
present with psychotic symptoms (48, 49). Nevertheless, we
did not ﬁnd any regional associations for the PANSS positive
symptom domain. Given the limited power of our meta-

Studies enrolling patients on higher doses of antipsychotics
are associated with larger rCBF/rCMRglu effects in the left
striatum. The effect of antipsychotics on striatal rCBF in
schizophrenia has been studied extensively, and our results are
highly consistent with the synthesis reported by Goozé e et al.
(44). Striatal D2 blockade seems to have a direct effect on
increasing metabolism as well as blood ﬂow of striatum, while
other brain regions do not exhibit a relationship of similar
magnitude. Increased rCBF/rCMRglu of temporal pole is
consistent with medial temporal lobe pathology that has been
reported in the literature (45–47). Given that the posited
function of the temporal pole is one of emotion-perception
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strength as a marker of study quality as both patients and controls in
such studies were scanned using the same instrument, obviating any
measurement bias. Nevertheless, it is likely that the lower SNR
might have contributed to publication bias, with only a few 1.5 T
studies with positive results are reported in the literature. Finally,
our results do not demonstrate that metabolic and vascular
abnormalities are necessarily correlated at the subject (or group)
level. Our aim was more modest, and restricted to localizing those
brain regions where both abnormalities coexist in schizophrenia.
To conclude, schizophrenia related regional perfusion
abnormalities capture the aberrant metabolism of underlying
neuro-glial tissue. In speciﬁc brain regions, such as the
dorsomedial prefrontal cortex, neurovascular uncoupling
suggestive of possible inﬂammation (causing inappropriate
hyperemia), astroglial dysfunction, or mitochondrial defects
are likely to be present. This uncoupling needs further
characterization, possibly using hybrid PET/MRI, to establish a
mechanistic basis. These observations raise an interesting question
of whether focused pharmacological restoration of blood-ﬂow
regulation could alleviate symptoms of schizophrenia.

regression approach, we urge caution in interpreting these
negative results.
We observed rCBF/rCMRglu uncoupling in two sites:
dorsomedial prefrontal cortex and cerebellar vermis. In
particular, a large body of fMRI studies indicate that the BOLD
signal in the dorsomedial prefrontal cortex is reduced when control/
conﬂict-processing tasks are performed by patients, compared to
healthy subjects (50). Our current results indicate that these BOLD
results are likely driven by reduced synaptic activity rather than a
perfusion deﬁcit in this region. The presence of normal rCBF in a
site with reduced rCMRglu indicates a relative hyperperfusion,
and resonates with the observation made by Taylor et al. (51)
who demonstrated that ACC region demonstrates a relative
hyperperfusion in subjects with schizophrenia.
Coupling of CMRglu and CBF appears to be linked to a
vasoactive mechanism, as well as a structural factor related to
capillary density (52). Postmortem studies in schizophrenia have
not uncovered any notable vascular structural pathology to date,
except for an increase in astrocytic end-feet in the prefrontal
cortex shown by one study (53). In certain mitochondrial
encephalopathies and lactic acidosis, uncoupling of rCBF and
CMRglu occurs (54, 55), indicating that alterations in oxidative
stress pathways may be relevant to our current observation in
schizophrenia. In experimental models, neurovascular coupling
is impaired in young rodents when redox imbalance is created by
increasing intracellular generation of superoxide radicals (56).
Glutathione, a major intracellular antioxidant that protects
neuroglia from oxidative stress by disposing peroxides, is
notably reduced in schizophrenia particularly in the medial
prefrontal cortex (57), especially in patients with poor
outcomes (58, 59). Taken together, our results support the
likely existence of redox imbalance in the medial prefrontal
cortex of patients with schizophrenia.
There are several limitations in this review that should be
considered when interpreting results. Firstly, the cerebellar
disjunction ﬁndings must be considered with caution as the
quality of ASL signals from this region has been suboptimal in
many studies. The lack of cerebellar coverage as well as the inﬂuence
of ASL labeling site on posterior cerebral circulation may have
inﬂuenced the reported disjunction. Secondly, all of the reported
PET studies used CT-based anatomical registration, while ASL uses
MR-based information. This might have inﬂuenced the exact
location of peak coordinates, though the spatial smoothing used
in SDM mitigates this to some extent. We also urge caution in
interpreting the negative results from meta-regression (i.e. lack of
age, gender and severity effects on metabolism) as none of the
individual studies were powered to detect these relationships, and
the meta-regression approach cannot deal with non-linear effects.
Furthermore, we acknowledge that the meta-regression is
exploratory as this analysis is likely to be underpowered.
Similarly, disjunction results could also be driven by the wellknown issue of false negative results from coordinates based
meta-analyses (60). Only one ASL study employed 1.5T scanner
(15), and our Jack-knife sensitivity analysis indicated that dropping
this study did not alter the overall results. We did not use scanner
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